Skip to content

Disc Medicine IRON Interest Paid

Interest Paid at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$3.2M+18.5%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$0
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$2.21M0.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$20.32M-12.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.16M0.0%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's interest paid?
Disc Medicine (IRON) reported interest paid of $640K in Q1 2026.
How has Disc Medicine's interest paid changed year-over-year?
Disc Medicine's interest paid decreased by 8.3% year-over-year, from $698K to $640K.
What is the long-term trend for Disc Medicine's interest paid?
Over 3 years (2021 to 2025), Disc Medicine's interest paid has grown at a 108.8% compound annual growth rate (CAGR), from $307K to $2.8M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.